Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | KIF11 | P52732 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27791554 | 0.86 | CYP1A2 (0.47) | CYP1A2CYP2C19HIF1ACYP2D6TSHR | |
| SCHEMBL27466589 | 0.84 | CYP1A2 (0.50) | CYP1A2CYP2C19HIF1ACYP2D6TSHR | |
| SCHEMBL2032135 | 0.84 | MAPT (0.52) | CYP1A2CYP2C19HIF1ACYP2D6TSHR | |
| SCHEMBL7525391 | 0.84 | MIF (0.48) | CYP1A2CYP2C19HIF1ACYP2D6TSHR | |
| SCHEMBL27324484 | 0.81 | KCNN4 (0.43) | CYP1A2CYP2C19HIF1ACYP2D6TSHR | |
| SCHEMBL3384635 | 0.81 | CYP1A2 (0.56) | CYP1A2CYP2C19HIF1ACYP2D6TSHR | |
| SCHEMBL15228092 | 0.79 | CYP1A2 (0.54) | CYP1A2CYP2C19HIF1ACYP2D6TSHR | |
| SCHEMBL15125011 | 0.79 | CYP1A2 (0.54) | CYP1A2CYP2C19HIF1ACYP2D6TSHR | |
| SCHEMBL2456548 | 0.79 | CYP1A2 (0.54) | CYP1A2CYP2C19HIF1ACYP2D6TSHR | |
| SCHEMBL28130890 | 0.79 | TSHR (0.41) | CYP1A2CYP2C19HIF1ATSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2033635-A1 | Short-chain fatty acid derivatives for treating pruritus | Asan Laboratories Company (Cayman) Limited (CN) | 2009-03-11 | — | — | EP | claimed |
| EP-1951813-A1 | METHOD OF REDUCING THE STYRENE CONTENT OF A POLY (ARYLENE ETHER) POLYSTYRENE BLEND, AND ARTICLES COMPRISING THE RESULTING THERMOPLASTIC RESIN | General Electric Company (US) | 2008-08-06 | — | — | EP | claimed |
| US-20080107646-A1 | Administering phenylbutyric acid derivative and pharmaceutically acceptable carrier | Sunny Pharmtech Inc. (TW) | 2008-05-08 | — | — | US | claimed |
| US-7314909-B2 | Method of reducing the styrene content of a poly(arylene ether)/polystyrene blend, and articles comprising the resulting thermoplastic resin | GENERAL ELECTRIC COMPANY (US) | 2008-01-01 | — | — | US | claimed |
| WO-2007047217-A1 | METHOD OF REDUCING THE STYRENE CONTENT OF A POLY (ARYLENE ETHER) POLYSTYRENE BLEND, AND ARTICLES COMPRISING THE RESULTING THERMOPLASTIC RESIN | GENERAL ELECTRIC COMPANY (US) | 2007-04-26 | — | — | WO | claimed |
| US-20070083035-A1 | Method of reducing the styrene content of a poly(arylene ether)/polystyrene blend, and articles comprising the resulting thermoplastic resin | SABIC GLOBAL TECHNOLOGIES IP B.V. (NL) | 2007-04-12 | — | — | US | claimed |
| EP-1113028-B1 | Process for production of olefin polymer with long chain branching | BAYER AG (US) | 2004-03-31 | — | — | EP | claimed |
| US-6403646-B1 | ADMINISTERING PHENYLBUTYRIC ACID OR DERIVATIVES TO TREAT LIVER DISEASE AND EMPHYSEMA CAUSED BY PROTEASE INHIBITOR TYPE Z MUTATION; STIMULATES SECRETION WITHOUT INCREASING SYNTHESIS OF PROTEIN | PERLMUTTER DAVID H (US) | 2002-06-11 | — | — | US | claimed |
| CN-113861019-A | Continuous production method for recovering phenylacetic acid from 7-amino-3-vinyl cephalosporanic acid production wastewater | 山东普洛得邦医药有限公司 | 2021-12-31 | — | — | CN | disclosed |
| CN-110923223-B | Novel nitrilase and application thereof | 中山大学 | 2021-10-08 | — | — | CN | disclosed |
| CN-109415355-A | Benzdioxan derivative and its medicinal usage | 奥赖恩公司 | 2019-03-01 | — | — | CN | disclosed |
| EP-2872524-B1 | 3-SUBSTITUTED ESTRA-1,3,5(10),16-TETRAENE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAME, AND USE THEREOF FOR THE PRODUCTION OF MEDICAMENTS | Bayer Pharma AG (DE) | 2016-08-24 | — | — | EP | disclosed |
| EP-2872524-A1 | 3-SUBSTITUTED ESTRA-1,3,5(10),16-TETRAENE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAME, AND USE THEREOF FOR THE PRODUCTION OF MEDICAMENTS | Bayer Pharma Aktiengesellschaft (DE) | 2015-05-20 | — | — | EP | disclosed |
| US-8846039-B2 | Method for ameliorating pruritus | ASAN LABORATORIES COMPANY (CAYMAN), LIMITED (TW) | 2014-09-30 | — | — | US | disclosed |
| WO-1996038528-A1 | BETAINE ESTERS FOR DELIVERY OF ALCOHOLS | THE PROCTER & GAMBLE COMPANY (US) | 1996-12-05 | — | — | WO | disclosed |
| EP-0725635-A1 | PHENYLACETATE AND DERIVATIVES ALONE OR IN COMBINATION WITH OTHER COMPOUNDS AGAINST NEOPLASTIC CONDITIONS AND OTHER DISORDERS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-08-14 | — | — | EP | disclosed |
| WO-1995010271-A2 | PHENYLACETATE AND DERIVATIVES ALONE OR IN COMBINATION WITH OTHER COMPOUNDS AGAINST NEOPLASTIC CONDITIONS AND OTHER DISORDERS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-04-20 | — | — | WO | disclosed |
| EP-0138403-B1 | PROCESS FOR PREPARING PHOSPHINIC ACID INTERMEDIATES | E.R. Squibb & Sons, Inc. (US) | 1989-03-15 | — | — | EP | disclosed |
| US-4602092-A | Method for making phosphinic acid intermediates | E. R. SQUIBB & SONS, INC. (US) | 1986-07-22 | — | — | US | disclosed |
| EP-0138403-A2 | Process for preparing phosphinic acid intermediates | E.R. Squibb & Sons, Inc. (US) | 1985-04-24 | — | — | EP | disclosed |